急性骨髄性白血病
Also known as AML - acute Myeloid Leukemia, Leukemia, Myelocytic, acute, acute myeloblastic leukemia, acute myelogenous leukemia, Acute myelogenous leukemia; AML, Acute Granulocytic Leukemia, LEUKEMIA, ACUTE MYELOID; AML, Acute non lymphoblastic leukemia
白血病の一つ
Key facts
- Other names
- Acute myelogenous leukemia, acute nonlymphocytic leukemia (ANLL), acute myeloblastic leukemia, acute granulocytic leukemia
- Specialty
- Hematology , oncology
- Symptoms
- Feeling tired, shortness of breath , easy bruising and bleeding, increased risk of infection
- Usual onset
- 65–70 years old
- Risk factors
- Smoking , previous chemotherapy or radiation therapy , myelodysplastic syndrome , benzene
- Diagnostic method
- Bone marrow aspiration , blood test
- Treatment
- Chemotherapy , radiation therapy , stem cell transplant , Targeted inhibitors
- Prognosis
- Five-year survival ~33% (US, 2015–2021)
- Frequency
- 145,000 per year (2021)
- Deaths
- 130,000 (2021)
via Wikipedia infobox
Wikidata facts
Article · 日本語
急性骨髄性白血病（きゅうせいこつずいせいはっけつびょう、英: acute myelogenous leukemia、略称:AML）は、白血病の一種で、骨髄系の造血細胞が悪性腫瘍化し、分化・成熟能を失う疾患である。
Abstract from DBpedia / Wikipedia · CC BY-SA